...
首页> 外文期刊>Journal of experimental & clinical cancer research : >Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
【24h】

Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.

机译:乳腺导管浸润癌的纯原位导管癌和原位成分。初步的形态计量学研究。

获取原文
获取原文并翻译 | 示例

摘要

Nuclear pleomorphism is a fundamental feature in evaluating the aggressiveness of ductal carcinoma in situ (DCIS) of the breast. In this study, pure DCIS and the in situ component (IS-comp) of invasive duct carcinoma (IDC) are compared in order to verify if these are two different entities or the same process observed at different times during its evolution. Five cases of pure DCIS and nine of IDC with extensive in situ component were selected. They were moderately and poorly differentiated. 30 nuclei for each DCIS, and 30 nuclei for both the in situ and invasive component of each IDC were studied; thus, a total of 720 nuclei were submitted to the SAM (Shape Analytical Morphometry) analysis, which enables a numerical expression not only of dimensions (area, perimeter, diameter) but also of nuclear contour irregularities and nuclear shape distortions. Univariate statistical comparisons were carried out between the nuclei of: (1) DCIS and in situ component of invasive duct carcinoma, (2) DCIS and the invasive component of infiltrating carcinoma and (3) between the in situ and invasive component of infiltrating carcinoma. Multivariate analysis was utilized to compare nuclei of DCIS with the in situ component of IDC. The in situ features of each tumor were also evaluated with the mitotic index (MI). Nuclei of pure DCIS resulted significantly larger (p < 0.001) and with a more regular shape (p < 0.001) than those of the in situ component of IDC. No differences were observed between the nuclei of the in situ and the invasive component of infiltrating carcinomas. Multivariate statistical analysis discriminated 77% of nuclei of in situ proliferation when both G2 and G3 tumors were considered, and 80% when only G3 tumors were considered. In conclusions morphological differences exist between pure DCIS and the in situ component of IDC, which may be an expression of their biological behavior; moreover, these morphological differences seem to have a better discriminating power within the same histological grade.
机译:核多态性是评估乳腺导管原位癌(DCIS)的侵袭性的基本特征。在本研究中,比较了纯DCIS和浸润性导管癌(IDC)的原位成分(IS-comp),以验证它们是两个不同的实体还是在进化过程中的不同时间观察到的同一过程。选择了5例纯DCIS病例和9例IDC具有广泛原位成分的病例。他们是中等和低分化。研究了每个DCIS的30个核,以及每个IDC的原位和侵入成分的30个核;因此,总共720个核被提交给SAM(形状分析形态分析)分析,这不仅使尺寸(面积,周长,直径)的数值表达成为可能,而且使核轮廓不规则和核形状畸变成为可能。在(1)DCIS和浸润性导管癌的原位成分,(2)DCIS和浸润性癌的浸润成分之间以及(3)浸润癌的原位和浸润成分之间进行单变量统计比较。利用多变量分析比较DCIS的核与IDC的原位成分。每个肿瘤的原位特征也用有丝分裂指数(MI)评估。与IDC的原位成分相比,纯DCIS的核显着更大(p <0.001)并且形状更规则(p <0.001)。在原位细胞核和浸润癌的浸润成分之间未观察到差异。当同时考虑G2和G3肿瘤时,多变量统计分析可区分出77%的原位增殖核,而仅考虑G3肿瘤时则可分辨出80%。结论是纯DCIS与IDC的原位成分之间存在形态学差异,这可能是其生物学行为的一种表达。此外,在相同的组织学等级上,这些形态学差异似乎具有更好的辨别力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号